Skip Navigation

This Article
Right arrow Abstract
Right arrow FREE Full Text
Right arrow E-letters: Submit a response
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrowRequest Permissions
Right arrow Disclaimer

Cetuximab in combination with weekly 5-fluorouracil/folinic acid and oxaliplatin (FUFOX) in untreated patients with advanced colorectal cancer: a phase Ib/II study of the AIO GI Group
Ann Oncol Arnold et al. 19: 1442

Supplementary Data

Data files

Files in this Data Supplement:



This Article
Right arrow Abstract
Right arrow FREE Full Text
Right arrow E-letters: Submit a response
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrowRequest Permissions
Right arrow Disclaimer